Cargando…

Successful Treatment of Human Immunodeficiency Virus-Associated Highly Active Antiretroviral Therapy-Resistant Vacuolar Myelopathy with Intravenous Immunoglobulin

For the first time, human immunodeficiency virus (HIV)-associated vacuolar myelopathy (VM) was detailed in an autopsy-based study of 89 cases in 1985. This condition is the most common cause for spinal cord lesions in HIV patients. VM's pathogenic mechanism remains unclear; however, it is assum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prakhova, Lidiia N., Ilves, Aleksandr G., Kizhlo, Svetlana N., Savintseva, Zhanna I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061500/ https://www.ncbi.nlm.nih.gov/pubmed/32189866 http://dx.doi.org/10.4103/aian.AIAN_255_18

Ejemplares similares

Two Clinical Cases of LBSL: Diagnostic Problems and Possible Therapeutic Approaches
por: Bedova, Mariia A., et al.
Publicado: (2020)

Spastic paraparesis caused by X-linked adrenoleukodystrophy mimicking vacuolar myelopathy in a human immunodeficiency virus patient: A case report
por: Park, Jin-Sung, et al.
Publicado: (2018)

Atypical HIV-vacuolar myelopathy: a case report
por: Mongezi, Tau, et al.
Publicado: (2021)

HIV-associated vacuolar myelopathy: A rare initial presentation of HIV
por: Rezaie, Aida, et al.
Publicado: (2020)

Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report
por: Akagi, Kazumasa, et al.
Publicado: (2020)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

HIV-Associated Vacuolar Myelopathy and HIV-Associated Dementia as the Initial Manifestation of HIV/AIDS
por: Wuliji, Natalia, et al.
Publicado: (2019)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012)

Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy?
por: Memmedova, Lale, et al.
Publicado: (2013)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
por: Gill, Parwinder K., et al.
Publicado: (2018)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection
por: Asaduzzaman, Md, et al.
Publicado: (2023)

Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
por: Olson, Rose M., et al.
Publicado: (2018)

Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin
por: Fukazawa, Ryosuke, et al.
Publicado: (2020)

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
por: Schroeder, H. W., et al.
Publicado: (2012)

Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
por: Hasegawa, Mizue, et al.
Publicado: (2017)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

An Atypical Presentation of West Nile Virus With Successful Treatment After Plasma Exchange and Intravenous Immunoglobulin
por: Malone, Kevin, et al.
Publicado: (2022)

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
por: Dolenc-Voljč, M., et al.
Publicado: (2013)

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
por: Lanza, Maurizia, et al.
Publicado: (2020)

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia
por: Haage, Tobias R., et al.
Publicado: (2022)

Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur
por: Sharma, Adhikarimayum Lakhikumar, et al.
Publicado: (2018)

Virus safety of intravenous immunoglobulin: Future challenges
por: Boschetti, Nicola, et al.
Publicado: (2005)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
por: Hassin, Ori, et al.
Publicado: (2021)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
por: Kim, Jeffrey, et al.
Publicado: (2023)

May early intervention with intravenous immunoglobulin pose a potentially successful treatment for Ebola virus infection?
por: Ge, Ying, et al.
Publicado: (2014)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
por: Sudharshan, Sridharan, et al.
Publicado: (2020)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy
por: Spadaro, Giuseppe, et al.
Publicado: (2011)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency
por: Ricci, Silvia, et al.
Publicado: (2020)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis
por: Lemos, Larissa de Araújo, et al.
Publicado: (2016)

Conjunctival Flora of Human Immunodeficiency Virus Patients on Antiretroviral Treatment
por: Giles, Kagmeni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v5h1ao53judarh28ob9ni8bq08